Unknown

Dataset Information

0

Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.


ABSTRACT: Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined deficiency in either HAI-1 or HAI-2, along with genes encoding developmentally co-expressed candidate matriptase targets, and screening for the rescue of embryonic development. Hypomorphic mutations in Prss8, encoding the GPI-anchored serine protease, prostasin (CAP1, PRSS8), restored placentation and normal development of HAI-1-deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2-deficient embryos. Inactivation of genes encoding c-Met, protease-activated receptor-2 (PAR-2), or the epithelial sodium channel (ENaC) alpha subunit all failed to rescue embryonic lethality, suggesting that deregulated matriptase-prostasin activity causes developmental failure independent of aberrant c-Met and PAR-2 signaling or impaired epithelial sodium transport. Furthermore, phenotypic analysis of PAR-1 and matriptase double-deficient embryos suggests that the protease may not be critical for focal proteolytic activation of PAR-2 during neural tube closure. Paradoxically, although matriptase auto-activates and is a well-established upstream epidermal activator of prostasin, biochemical analysis of matriptase- and prostasin-deficient placental tissues revealed a requirement of prostasin for conversion of the matriptase zymogen to active matriptase, whereas prostasin zymogen activation was matriptase-independent.

SUBMITTER: Szabo R 

PROVIDER: S-EPMC3431340 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Szabo Roman R   Uzzun Sales Katiuchia K   Kosa Peter P   Shylo Natalia A NA   Godiksen Sine S   Hansen Karina K KK   Friis Stine S   Gutkind J Silvio JS   Vogel Lotte K LK   Hummler Edith E   Camerer Eric E   Bugge Thomas H TH  

PLoS genetics 20120830 8


Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined defi  ...[more]

Similar Datasets

| S-EPMC4139241 | biostudies-literature
| S-EPMC6331135 | biostudies-literature
| S-EPMC3105307 | biostudies-literature
| S-EPMC9224322 | biostudies-literature
| S-EPMC10417574 | biostudies-literature
| S-EPMC5491767 | biostudies-literature
| S-EPMC4314694 | biostudies-literature
| S-EPMC10482385 | biostudies-literature
| S-EPMC1891898 | biostudies-literature
| S-EPMC3214967 | biostudies-literature